Tuberculosis on a Medical Elective: How to Stay Safe

Tuberculosis on a Medical Elective: How to Stay Safe

If you are doing a clinical placement in South Asia, Southeast Asia or East Africa, tuberculosis is the single infection most likely to follow you home from the ward. Tuberculosis is a bacterial disease, caused by Mycobacterium tuberculosis, that usually attacks the lungs and spreads through the air when someone with the disease coughs, sneezes or spits. You cannot vaccinate your way out of it as an adult, and you will not always know which patient has it. What you can do: understand where the risk sits, wear the right mask in the right rooms, and get tested at the right time afterwards.

How big is the tuberculosis risk on a clinical elective?

Bigger than most students assume, smaller than the internet suggests. Tuberculosis is airborne, so the risk comes from time in poorly ventilated rooms with undiagnosed coughing patients. A four week placement on a busy medicine ward carries a genuine chance of exposure, but exposure is not disease, and most infections stay silent for life.

WHO estimates that around a quarter of the world's population has been infected with TB bacteria, and that 5% to 10% of them eventually develop symptoms. In 2024, about 87% of new cases occurred in the 30 high burden countries, with eight carrying two thirds of the world total.

Notice Indonesia in second place. Bali is one of our four placement countries, which is why we would rather you read this than find out on your first shift.

Which of the four travel4med destinations has the most tuberculosis?

Indonesia, by a wide margin, and Sri Lanka the least. The table uses WHO's 2024 estimates of new cases per 100 000 people per year from the Global Health Observatory. Read them as national figures, because that is what they are. One hospital's caseload can sit well above or below its country's average.

One honest caveat on Zanzibar: the 172 figure covers the whole United Republic of Tanzania, and Zanzibar's semi-autonomous health system reports separately, so read it as an order of magnitude, not a local rate. For the local picture, our destination guides for Bali, Nepal, Sri Lanka and Zanzibar describe the hospitals you would actually be placed in.

What does the research on students and trainees actually show?

That trainees in high burden hospitals get infected at a rate you would not accept at home. The cleanest evidence is a prospective cohort of 200 medical residents and nursing students at one Indian hospital, followed from May 2016 to December 2017 by Kinikar and colleagues, tested at entry and again at 12 months.

Three numbers are worth carrying with you. Latent infection was already present in 30% of participants at enrolment. Over the next year, new infections appeared at 26.8 cases per 100 person-years. And six people, 3% of the cohort, were diagnosed with active TB disease during the study.

That last figure is the one that should make you reach for a mask. Note the scope, though: one hospital, one high burden country, one year, and India's national incidence (187 per 100 000 in 2024) sits below Indonesia's. It is not a global average for electives.

What is the difference between TB infection and TB disease?

Latent TB infection means the bacteria are in your body but contained: you feel well, you are not contagious, and a chest X-ray is usually normal. TB disease means they are multiplying and causing symptoms. Roughly 5% to 10% of latent infections progress to disease at some point, and WHO recommends treatment for both states.

The symptoms are unglamorous and easy to dismiss: a cough lasting more than two or three weeks, chest pain, fever, night sweats, unexplained weight loss, fatigue. Sound like the tail end of a long placement plus jet lag? That is precisely why people miss it. Two tests pick up infection rather than disease: a tuberculin skin test and an interferon gamma release assay (IGRA, a blood test).

How do you protect yourself on a busy ward?

By treating airborne precautions as your default, not a reaction. WHO's consolidated guidelines on TB prevention and infection control, published 12 September 2022, set out three layers: administrative measures, environmental controls such as ventilation, and respiratory protection. As a visiting student you control the third layer well and the second a little.

1. Pack your own respirators. Bring fit-tested FFP2, FFP3 or N95 respirators from home. Many hospitals stock surgical masks in abundance and respirators only in specific units.
2. Wear one in the high risk rooms every time. Respiratory medicine, the TB clinic, sputum induction, bronchoscopy, HIV wards, and any crowded waiting area full of coughing patients.
3. Get the seal right. A gap at the nose bridge turns a respirator into a surgical mask. Practise at home first.
4. Use the windows. Open air disperses TB bacteria far better than a closed room with a fan. Moving a consultation to a veranda is a real intervention, not a gesture.
5. Stand out of the cough plume. Position yourself beside or behind a coughing patient, and step back during sputum collection.
6. Ask which patients are on treatment. Someone two weeks into effective therapy is far lower risk than an undiagnosed admission. The team knows; just ask.
7. Look after your own health. Poor sleep, undernutrition and uncontrolled diabetes all raise the chance an infection becomes disease.

Not sure what your host hospital can provide? Ask before you book. Our team knows the wards and the mask supply at each partner site. Book a free consultation and we will tell you plainly what to bring.

What should you sort out before you fly?

A baseline test, a conversation with your faculty, and cover that would actually pay out. None of it takes long, but all three are much harder to arrange retrospectively. Give yourself six to eight weeks, the same lead time as travel vaccines.

1. Get a baseline IGRA or skin test. Without a pre-travel result, a positive test afterwards cannot tell anyone whether you were infected on this placement, on an earlier one, or years ago.
2. Ask your faculty's elective office what it requires. Some schools mandate screening before and after a high incidence placement; others leave it entirely to you.
3. Speak to your university occupational health service. They hold your baseline, order the follow-up and handle a conversion.
4. Check your BCG status. BCG mainly protects small children against severe forms of TB. A childhood scar changes very little about your ward precautions.
5. Confirm your insurance covers occupational exposure. Read the wording, not the brochure. Our guide to medical elective insurance walks through the clauses that matter.
6. Sort the rest of your travel health at the same appointment. Our vaccinations guide covers these four countries.

What should you do after you get home?

Get retested, at the right moment, and tell whoever reads the result where you have been. Immune tests need time to turn positive, so one taken the week you land can miss a recent infection. Most occupational health services retest around eight to twelve weeks after the last exposure. Confirm the interval with yours.

1. Book the follow-up test for roughly two to three months after your final ward day.
2. Bring your baseline result so the two can be compared directly.
3. Say where you worked, which wards, and for how long. That context changes how a borderline result is read.
4. Report any symptoms immediately instead of waiting for the scheduled test. A cough lasting over two to three weeks, night sweats or weight loss all warrant urgent review.
5. If your test has converted, discuss preventive treatment. Latent infection is treatable, and finishing the course is what prevents disease later.

Worth knowing: in that Indian cohort, 60 participants with latent infection were offered free preventive therapy and only two finished it. Being offered treatment and taking it are not the same thing.

Drug-resistant TB, in plain words

Multidrug-resistant TB no longer responds to rifampicin and isoniazid, the two most effective first line drugs. It is treatable, but with medicines that cost more, take longer and cause more side effects. WHO reports that only about two in five people with drug-resistant TB accessed treatment in 2024, which tells you how strained the pathways still are.

So the mask matters more, not less, in a hospital treating resistant cases. So does knowing your exposure history precisely: a vague "somewhere in Asia" is no help to a clinician choosing your preventive treatment. Same logic for blood and body fluid exposures, covered in our guide to needlestick injuries.

Who actually decides what you need?

Your own faculty and your own national regulator, not us and not your host hospital. Screening requirements are set by the medical or nursing school that signs off your placement, and they vary widely between countries and even between universities in one country. There is no international rule to look up.

So make two calls before you book flights. Ask your faculty's elective office, in writing, what screening they require and who pays. Then ask occupational health what they test, when, and whether they will hold your baseline. Your host hospital's answer is useful but not binding at home. Our post on clinical skills on a medical elective covers the clinical side.

Medically reviewed by MUDr. Amandeep Grewal, a doctor on the travel4med team whose review scope covers vaccinations, tropical medicine, insurance and clinical content.

Frequently Asked Questions

Sources

• World Health Organization, "Tuberculosis" fact sheet, 24 March 2026. Carries the 2024 totals, country shares, 5% to 10% progression, BCG, symptoms, TST and IGRA, drug-resistant treatment access. who.int
• World Health Organization, Global Health Observatory, "Incidence of tuberculosis (per 100 000 population per year)", 2024 estimates. Every per 100 000 figure here. who.int/data/gho
• World Health Organization, "WHO consolidated guidelines on tuberculosis: Module 1: Prevention, infection prevention and control", 12 September 2022. The three control layers. who.int/publications
• World Health Organization, "Global tuberculosis report 2025", 12 November 2025. who.int/publications
• Kinikar A. et al., "High risk for latent tuberculosis infection among medical residents and nursing students in India", PLOS ONE, 2019. The cohort of 200 and its figures. PMC6613683